insights_auto
Why is ORX up 5,76%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,90 SEK
arrow_upward
+5,76%(+0,049) 1D
17 қар., 17:29:55 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
315,79 млн
Avg. vol.
790,03 м.
Volume
719,07 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,83 SEK
High
0,98 SEK
Low
0,83 SEK
Mkt. cap
315,79 млн
Avg. vol.
790,03 м.
Volume
719,07 м.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
BigGo Finance
·
7 сағат бұрын
New York Stocks Fall for Fourth Straight Session Ahead of Nvidia Earnings; Dow Plunges 1.6%
ChartMill
·
8 сағат бұрын
S&P 500 After-Hours Gainers for Nov. 17, 2026
Fox Business
·
10 сағат бұрын
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
Traders Union
·
4 сағат бұрын
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com